Development of an Adjuvant-Free COVID-19 Vaccine for Mucosal Immunity (IMAGE)
Caption
Universities and medical institutions in Japan established a task force to examine genes associated with COVID-19 immune response by collecting samples from Japanese patients, aiming to apply their findings to the development of mucosal vaccine.
Credit
Osaka University
Usage Restrictions
None
License
Licensed content